Showing 1 - 16 results of 16 for search 'Christopher M. Counter', query time: 0.05s Refine Results
  1. 1
    Reduced HRAS G12V-Driven Tumorigenesis of Cell Lines Expressing KRAS C118S.

    Reduced HRAS G12V-Driven Tumorigenesis of Cell Lines Expressing KRAS C118S. by Lu Huang, Christopher M Counter

    Published 2015-01-01
    Get full text
    Article
  2. 2
    Cell cycle regulated phosphorylation of the telomere-associated protein TIN2.

    Cell cycle regulated phosphorylation of the telomere-associated protein TIN2. by Shuqun Yang, Christopher M Counter

    Published 2013-01-01
    Get full text
    Article
  3. 3
    Non-canonical genomic driver mutations of urethane carcinogenesis.

    Non-canonical genomic driver mutations of urethane carcinogenesis. by Siqi Li, Christopher M Counter

    Published 2022-01-01
    Get full text
    Article
  4. 4
    Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability

    Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability by Hema Adhikari, Christopher M. Counter

    Published 2018-09-01
    Get full text
    Article
  5. 5
    Signaling levels mold the RAS mutation tropism of urethane

    Signaling levels mold the RAS mutation tropism of urethane by Siqi Li, Christopher M Counter

    Published 2021-05-01
    Get full text
    Article
  6. 6
    p53 dosage can impede KrasG12D- and KrasQ61R-mediated tumorigenesis.

    p53 dosage can impede KrasG12D- and KrasQ61R-mediated tumorigenesis. by Özgün Le Roux, Jeffery I Everitt, Christopher M Counter

    Published 2024-01-01
    Get full text
    Article
  7. 7
    Expression of transgenes enriched in rare codons is enhanced by the MAPK pathway

    Expression of transgenes enriched in rare codons is enhanced by the MAPK pathway by Jackson Peterson, Siqi Li, Erin Kaltenbrun, Ozgun Erdogan, Christopher M. Counter

    Published 2020-12-01
    Get full text
    Article
  8. 8
    Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice.

    Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice. by Jamie D Weyandt, John M Carney, Elizabeth N Pavlisko, MengMeng Xu, Christopher M Counter

    Published 2016-01-01
    Get full text
    Article
  9. 9
    Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity

    Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity by Hema Adhikari, Walaa E. Kattan, Shivesh Kumar, Pei Zhou, John F. Hancock, Christopher M. Counter

    Published 2021-09-01
    Get full text
    Article
  10. 10
    Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Cancer.

    Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Cancer. by Jamie D Weyandt, Benjamin L Lampson, Sherry Tang, Matthew Mastrodomenico, Diana M Cardona, Christopher M Counter

    Published 2015-01-01
    Get full text
    Article
  11. 11
    Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance

    Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance by Moiez Ali, Erin Kaltenbrun, Grace R. Anderson, Sarah Jo Stephens, Sabrina Arena, Alberto Bardelli, Christopher M. Counter, Kris C. Wood

    Published 2017-06-01
    Get full text
    Article
  12. 12
    Distinct responses to rare codons in select Drosophila tissues

    Distinct responses to rare codons in select Drosophila tissues by Scott R Allen, Rebeccah K Stewart, Michael Rogers, Ivan Jimenez Ruiz, Erez Cohen, Alain Laederach, Christopher M Counter, Jessica K Sawyer, Donald T Fox

    Published 2022-05-01
    Get full text
    Article
  13. 13
    Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis

    Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis by Özgün Le Roux, Nicole LK Pershing, Erin Kaltenbrun, Nicole J Newman, Jeffrey I Everitt, Elisa Baldelli, Mariaelena Pierobon, Emanuel F Petricoin, Christopher M Counter

    Published 2022-09-01
    Get full text
    Article
  14. 14
    Exploiting codon usage identifies intensity-specific modifiers of Ras/MAPK signaling in vivo.

    Exploiting codon usage identifies intensity-specific modifiers of Ras/MAPK signaling in vivo. by Jessica K Sawyer, Zahra Kabiri, Ruth A Montague, Scott R Allen, Rebeccah Stewart, Sarah V Paramore, Erez Cohen, Hamed Zaribafzadeh, Christopher M Counter, Donald T Fox

    Published 2020-12-01
    Get full text
    Article
  15. 15
    Utility of Telomerase-pot1 Fusion Protein in Vascular Tissue Engineering

    Utility of Telomerase-pot1 Fusion Protein in Vascular Tissue Engineering by Thomas H. Petersen, Thomas Hitchcock, Akihito Muto, Elizabeth A. Calle, Liping Zhao, Zhaodi Gong, Liqiong Gui, Alan Dardik, Dawn E. Bowles, Christopher M. Counter, Laura E. Niklason M.D., Ph.D.

    Published 2010-01-01
    Get full text
    Article
  16. 16
    A Genetic Porcine Model of Cancer.

    A Genetic Porcine Model of Cancer. by Lawrence B Schook, Tiago V Collares, Wenping Hu, Ying Liang, Fernanda M Rodrigues, Laurie A Rund, Kyle M Schachtschneider, Fabiana K Seixas, Kuldeep Singh, Kevin D Wells, Eric M Walters, Randall S Prather, Christopher M Counter

    Published 2015-01-01
    Get full text
    Article

Search Tools: